Product Introduction:
Ryzodeg Penfill 100 Units/ml is a combination insulin formulation by Novo Nordisk, designed for the effective management of diabetes mellitus. It contains Insulin Degludec (long-acting) and Insulin Aspart (rapid-acting), offering both basal and mealtime blood sugar control in a single injection. These cartridges are compatible with Novo Nordisk reusable insulin pens.
Uses:
-
Treatment of diabetes mellitus (Type 1 and Type 2)
-
Provides both basal and prandial (mealtime) insulin coverage
Benefits:
-
Combination of long-acting and rapid-acting insulin for better glycemic control
-
Fewer injections compared to separate basal and bolus insulin
-
Steady, prolonged glucose-lowering effect
-
Convenient use with reusable Novo Nordisk insulin pens
-
Reduces the risk of blood sugar fluctuations
Composition:
-
Insulin Degludec 70% (long-acting)
-
Insulin Aspart 30% (rapid-acting)
-
100 Units/ml, 3ml per cartridge, pack of 5 cartridges
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Injection site reactions (redness, swelling, itching)
-
Weight gain
-
Skin thickening or lumps at the injection site (lipodystrophy)
-
Rare allergic reactions
Safety Advice:
-
Use only with compatible Novo Nordisk insulin pens
-
Rotate injection sites to avoid skin problems
-
Do not share your pen or cartridges with others
-
Store in a refrigerator (2°C to 8°C); do not freeze
-
Once in use, can be kept at room temperature for up to 4 weeks
-
Consult your doctor for proper dosage and administration techniques
